Why There Could Be at Least 1 More Big Acquisition in the Cannabis Industry This YearThe Motley Fool • 03/24/21
Jazz Pharmaceuticals Announces Participation at the 10th Annual J.P. Morgan Napa Valley ForumPRNewsWire • 03/22/21
Jazz Pharmaceuticals and Hypersomnia Foundation Launch Campaign to Increase Understanding and Awareness of Idiopathic HypersomniaPRNewsWire • 03/18/21
Jazz Pharmaceuticals plc (JAZZ) CEO Bruce Cozadd on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/24/21
Jazz Pharmaceuticals Announces Participation at Cowen 41st Annual Healthcare ConferencePRNewsWire • 02/23/21
Jefferies Top Growth Stocks to Buy Include 2 Red-Hot Sports Betting Winners24/7 Wall Street • 02/22/21
Jazz Pharmaceuticals Completes Submission of Supplemental New Drug Application for Xywav™ (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic HypersomniaPRNewsWire • 02/16/21
Jazz Pharmaceuticals to Report 2020 Fourth Quarter Financial Results on February 23, 2021PRNewsWire • 02/09/21
Biogen, Fortinet, Kohl's, Pinterest, Snap and More Friday Afternoon Analyst Calls24/7 Wall Street • 02/05/21